Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INTEGrating Rapid Antigen TEsting for SARS-CoV-2 in Maternal, Neonatal and Child Health, HIV and Tuberculosis Services in Cameroon and Kenya: A Cluster Randomized Trial of Two Models

NCT05382130 is registered in ClinicalTrials.gov with Elizabeth Glaser Pediatric AIDS Foundation as lead sponsor.

NCT NCT05382130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INTEGrating Rapid Antigen TEsting for SARS-CoV-2 in Maternal, Neonatal and Child Health, HIV and Tuberculosis Services in Cameroon and Kenya: A Cluster Randomized Trial of Two Models
Lead sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Phase
Not applicable
Overall status
Completed
Start date
May 17, 2022
Completion date
March 31, 2023
Enrollment
152,082 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19